D
Daniel A. Culver
Researcher at Cleveland Clinic
Publications - 187
Citations - 7419
Daniel A. Culver is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Sarcoidosis & Medicine. The author has an hindex of 38, co-authored 159 publications receiving 5213 citations. Previous affiliations of Daniel A. Culver include Cleveland Clinic Lerner Research Institute.
Papers
More filters
Journal ArticleDOI
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
David H. Birnie,William H. Sauer,Frank Bogun,Joshua M. Cooper,Daniel A. Culver,Claire S. Duvernoy,Marc A. Judson,Jordana Kron,Davendra Mehta,Jens Cosedis Nielsen,Amit R. Patel,Tohru Ohe,Pekka Raatikainen,Kyoko Soejima +13 more
TL;DR: This research presents a meta-anatomy of the autonomic nervous system, a probabilistic model of how the immune system regulates emotion, language, and physical activity in relation to heart disease.
Journal ArticleDOI
A Concise Review of Pulmonary Sarcoidosis
TL;DR: There is increasing evidence to support that one or more infectious agents may cause sarcoidosis, although this organism may no longer be viable in the patient, and new and more potent antiinflammatory agents have been developed.
Journal ArticleDOI
Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline
Elliott D. Crouser,Lisa A. Maier,Kevin C. Wilson,Catherine A. Bonham,Adam S. Morgenthau,Karen C. Patterson,Karen C. Patterson,Eric Abston,Richard C. Bernstein,Ron Blankstein,Edward S. Chen,Daniel A. Culver,Wonder P. Drake,Marjolein Drent,Alicia K. Gerke,Michael Ghobrial,Praveen Govender,Nabeel Hamzeh,W. Ennis James,Marc A. Judson,Liz Kellermeyer,Shandra L Knight,Laura L. Koth,Venerino Poletti,Subha V. Raman,Melissa H. Tukey,Gloria Westney,Robert P. Baughman +27 more
TL;DR: The panel used systematic reviews of the evidence to inform clinical recommendations in favor of or against various diagnostic tests in patients with suspected or known sarcoidosis.
Journal ArticleDOI
Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial
Marc A. Judson,Robert P. Baughman,U Costabel,Susan Flavin,Kim Hung Lo,Mani S. Kavuru,Marjolein Drent,Daniel A. Culver,Gerald S. Davis,C.M. Fogarty,Gary W. Hunninghake,Alvin S. Teirstein,M. Mandel,Daniel McNally,L. Tanoue,Lee S. Newman,Y. Wasfi,Herbert Patrick,Milton D. Rossman,Ganesh Raghu,Om P. Sharma,David S. Wilkes,Henry Yeager,J.F. Donahue,M. Kaye,Nadera J. Sweiss,N. Vetter,Michiel Thomeer,Martin Brutsche,Laurent P. Nicod,Dominique Valeyre,P. Chanez,C Albera,Jan C. Grutters,Henk C. Hoogsteden,Joachim Müller-Quernheim,R. Bonnet,F. Kanniess +37 more
TL;DR: Infliximab may be beneficial compared with placebo in the treatment of extrapulmonary sarcoidosis in patients already receiving corticosteroids, as assessed by the severity tool described in the present study.
Journal ArticleDOI
Sarcoidosis in America. Analysis Based on Health Care Use.
Robert P. Baughman,Shelli Field,Ulrich Costabel,Ronald G. Crystal,Daniel A. Culver,Marjolein Drent,Marc A. Judson,Gerhard Wolff +7 more
TL;DR: For patients 18 years of age and older enrolled in a U.S. national administrative database, sarcoidosis was more common among African Americans, but it was reported for all four of the major ethnic groups studied.